In Reply:-Reference-Cited by-同舟云学术

In Reply:

Published:2003-08-01 Issue:15 Volume:21 Page:3004-3005
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Haferlach Torsten¹,Kern Wolfgang¹,Schoch Claudia¹,Hiddemann Wolfgang¹,Sauerland Maria Cristina²

Affiliation:

1. Ludwig-Maximilians University, München, Germany

2. Westfälische Wilhelms University, Muenster, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.99.091

Reference7 articles.

1. Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

2. Goasguen JE, Matsuo T, Cox C, et al: Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: Major importance of dysgranulopoiesis for remission and survival. Leukemia 6:520,1992–525,

3. Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patients

4. Kern W, Kohlmann A, Wuchter C, et al: Correlation of protein expression and gene expression in acute myeloid leukemia. Cytometry (in press)

5. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk prediction in MDS: independent validation of the IPSS-M—ready for routine?;Leukemia;2023-02-01

2. Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts;Leukemia;2022-12-03

3. SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis;Leukemia;2022-10-19

4. Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia;Leukemia;2019-11-12

5. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases;Leukemia;2016-09-29